542910 VALENCIA

Valencia Nutrition Share Price

₹41.10 -2.15 (-4.97%)

04 Mar, 2025 06:35

SIP TrendupStart SIP in VALENCIA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -21.95%
  • Over 3 Month -27.51%
  • Over 6 Month + 2.93%
  • Over 1 Year -55.14%
SIP Lightning

Smart Investing Starts Here Start SIP with Valencia Nutrition for Steady Growth!

Invest Now

Valencia Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Valencia Nutrition Financials

Valencia Nutrition Technicals

EMA & SMA

Current Price
₹41.10
-2.15 (-4.97%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹46.56
  • 50 Day
  • ₹47.43
  • 100 Day
  • ₹46.92
  • 200 Day
  • ₹41.96

Resistance and Support

41.1 Pivot Speed
  • R3 41.10
  • R2 41.10
  • R1 41.10
  • S1 41.10
  • S2 41.10
  • S3 41.10

What's your outlook on Valencia Nutrition?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Valencia Nutrition has an operating revenue of Rs. 4.99 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of -104% needs improvement, NULL The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 33% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 96 indicates it belongs to a poor industry group of Beverages-Non-Alcoholic and a Master Score of E is the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Valencia Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-13 Others Inter-alia, to consider 1. Fund Raising by the issue of permissible securities or through any other permissible mode. 2. Other business matters. alia, to consider : 1. Draft Letter of Offer for the proposed rights issue for an aggregate amount up to Rs. 22,00,00,000 (Rupees Twenty Two Crores Only)
2024-11-13 Half Yearly Results
2024-05-30 Audited Results
2023-12-30 Others Rs.0.00 alia, to consider : 1. Draft Letter of Offer for the proposed rights issue for an aggregate amount up to Rs. 22,00,00,000 (Rupees Twenty Two Crores Only)
2023-12-12 Others Inter alia, to consider : 1. Reclassification of Ms. Deepthi Anand from 'Promoter/Promoter Group' to 'Public Category pursuant to Regulation 31A of SEBI Regulations, 2015. issue of equity shares of Rs. 10/- in the ratio of 15:10 @ premium of Rs. 16/-.

Valencia Nutrition F&O

Valencia Nutrition Shareholding Pattern

61.94%
23.83%
14.23%

About Valencia Nutrition

  • NSE Symbol
  • VALENCIA
  • BSE Symbol
  • 542910
  • Managing Director
  • Mr. Manish Turakhia
  • ISIN
  • INE08RT01016

Similar Stocks to Valencia Nutrition

Valencia Nutrition FAQs

Valencia Nutrition share price is ₹41 As on 04 March, 2025 | 06:21

The Market Cap of Valencia Nutrition is ₹57.4 Cr As on 04 March, 2025 | 06:21

The P/E ratio of Valencia Nutrition is -41.4 As on 04 March, 2025 | 06:21

The PB ratio of Valencia Nutrition is 9.1 As on 04 March, 2025 | 06:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23